How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
QURALIS via GRANITE CAPITOL CONSULTING LLC
2026 · second_quarter · Q2
FDA Related issues
FDA Related Issues
FDA Related Issues
Source: Senate LDA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QURALIS via GRANITE CAPITOL CONSULTING LLC
2026 · first_quarter · Q1
FDA Related issues
FDA Related Issues
FDA Related Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QURALIS via GRANITE CAPITOL CONSULTING LLC
2025 · fourth_quarter · Q4
FDA Related issues
FDA Related Issues
FDA Related Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QURALIS via GRANITE CAPITOL CONSULTING LLC
2025 · third_quarter · Q3
FDA Related issues
FDA Related Issues
FDA Related Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QURALIS via GRANITE CAPITOL CONSULTING LLC
2025 · second_quarter · Q2
FDA Related issues
FDA Related Issues
FDA Related Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE